MYH7 and neoplasm: Tumor growth inhibition was observed in mice treated with combination therapy [SNCSS(Cas9/sgGDF15) and anti‐mPD1], SNCSS(Cas9/sgGDF15), and anti‐mPD1, as indicated by the bioluminescence signal intensity.